JP2020530778A5 - - Google Patents

Download PDF

Info

Publication number
JP2020530778A5
JP2020530778A5 JP2020523236A JP2020523236A JP2020530778A5 JP 2020530778 A5 JP2020530778 A5 JP 2020530778A5 JP 2020523236 A JP2020523236 A JP 2020523236A JP 2020523236 A JP2020523236 A JP 2020523236A JP 2020530778 A5 JP2020530778 A5 JP 2020530778A5
Authority
JP
Japan
Prior art keywords
recombinant dna
dna molecule
virus
mir
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020523236A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020530778A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/042136 external-priority patent/WO2019014623A1/en
Publication of JP2020530778A publication Critical patent/JP2020530778A/ja
Publication of JP2020530778A5 publication Critical patent/JP2020530778A5/ja
Priority to JP2023166265A priority Critical patent/JP2023165916A/ja
Pending legal-status Critical Current

Links

JP2020523236A 2017-07-14 2018-07-13 カプセル封入ポリヌクレオチド及び使用方法 Pending JP2020530778A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023166265A JP2023165916A (ja) 2017-07-14 2023-09-27 カプセル封入ポリヌクレオチド及び使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762532886P 2017-07-14 2017-07-14
US62/532,886 2017-07-14
US201862648651P 2018-03-27 2018-03-27
US62/648,651 2018-03-27
PCT/US2018/042136 WO2019014623A1 (en) 2017-07-14 2018-07-13 Encapsulated polynucleotides and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023166265A Division JP2023165916A (ja) 2017-07-14 2023-09-27 カプセル封入ポリヌクレオチド及び使用方法

Publications (2)

Publication Number Publication Date
JP2020530778A JP2020530778A (ja) 2020-10-29
JP2020530778A5 true JP2020530778A5 (cg-RX-API-DMAC7.html) 2021-08-12

Family

ID=65002120

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020523236A Pending JP2020530778A (ja) 2017-07-14 2018-07-13 カプセル封入ポリヌクレオチド及び使用方法
JP2023166265A Pending JP2023165916A (ja) 2017-07-14 2023-09-27 カプセル封入ポリヌクレオチド及び使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023166265A Pending JP2023165916A (ja) 2017-07-14 2023-09-27 カプセル封入ポリヌクレオチド及び使用方法

Country Status (13)

Country Link
US (1) US20200224220A1 (cg-RX-API-DMAC7.html)
EP (1) EP3652325A4 (cg-RX-API-DMAC7.html)
JP (2) JP2020530778A (cg-RX-API-DMAC7.html)
KR (1) KR20200036873A (cg-RX-API-DMAC7.html)
CN (1) CN111212914A (cg-RX-API-DMAC7.html)
AU (1) AU2018301701A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020000839A2 (cg-RX-API-DMAC7.html)
CA (1) CA3069821A1 (cg-RX-API-DMAC7.html)
IL (1) IL271969A (cg-RX-API-DMAC7.html)
MX (1) MX2020000495A (cg-RX-API-DMAC7.html)
RU (1) RU2020106730A (cg-RX-API-DMAC7.html)
SG (1) SG11202000312UA (cg-RX-API-DMAC7.html)
WO (1) WO2019014623A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020000993A (es) 2017-07-26 2020-07-22 Oncorus Inc Vectores virales oncolíticos y usos de estos.
MX2020001593A (es) 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.
SG11202006457YA (en) 2018-01-05 2020-08-28 Ottawa Hospital Res Inst Modified orthopoxvirus vectors
US20200405791A1 (en) * 2018-03-12 2020-12-31 Mayo Foundation For Medical Education And Research Using infectious nucleic acid to treat cancer
JP7602454B2 (ja) 2018-08-09 2024-12-18 バイオベラティブ セラピューティクス インコーポレイテッド 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
CA3117924A1 (en) * 2018-11-13 2020-05-22 Oncorus, Inc. Encapsulated polynucleotides and methods of use
CA3124524A1 (en) * 2019-01-04 2020-07-09 Oncorus, Inc. Encapsulated rna polynucleotides and methods of use
US12209250B2 (en) * 2019-03-14 2025-01-28 Massachusetts Institute Of Technology Engineered Herpes Simplex Virus-1 (HSV-1) vectors and uses thereof
JP2022543610A (ja) * 2019-08-05 2022-10-13 ヴァイロジン バイオテック カナダ リミテッド 遺伝子改変エンテロウイルスベクター
CN114765990A (zh) * 2019-10-10 2022-07-19 昂克诺斯公司 双重病毒和双重溶瘤病毒以及治疗方法
EP4157456A4 (en) * 2020-05-29 2024-06-26 Oncorus, Inc. ENCAPSULATED RNA REPLIKONS AND METHODS OF USE
EP4164596A1 (en) * 2020-06-11 2023-04-19 eTheRNA Immunotherapies NV Lipid nanoparticles
US20230242994A1 (en) * 2020-07-10 2023-08-03 Shanghai Miran Biotech Co., Ltd. Fluorescent cross-linked rnase h mutant conjugate, mirna combination and application thereof
CA3204244A1 (en) * 2021-01-06 2022-07-14 Lorena Lerner Encapsulated rna polynucleotides and methods of use
CN113368261A (zh) * 2021-06-17 2021-09-10 苏州大学 一种非病毒载体及其制备方法与应用
WO2023069948A1 (en) 2021-10-18 2023-04-27 Flagship Pioneering Innovations Vii, Llc Dna compositions and related methods
US20250304999A1 (en) * 2022-05-20 2025-10-02 Virogin Biotech Canada Ltd Genetically modified enterovirus vectors with enhanced genomic stability
JP7229412B1 (ja) 2022-06-14 2023-02-27 キユーピー株式会社 脂質ナノ粒子及びその製造方法
CN118634240A (zh) * 2022-06-27 2024-09-13 浙江大学 抗口腔肿瘤药物活性成分及其用途
KR20260043572A (ko) * 2024-09-24 2026-03-31 고려대학교 산학협력단 폐암 치료를 위한 페메트렉시드-기능화 종양 미세환경 표적 흡입용 약물전달시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004274860A1 (en) * 2003-05-28 2005-03-31 Wisconsin Alumni Research Foundation Recombinant influenza vectors with a polII promoter and ribozymes
DK1668025T3 (da) * 2003-09-26 2014-08-25 Novartis Ag Seneca Valley-virusbaserede præparater og fremgangsmåder til behandling af sygdom
US7473418B2 (en) * 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
GB0810912D0 (en) * 2008-06-13 2008-07-23 Inst Animal Health Ltd Vector
DK2346995T3 (en) * 2008-09-26 2019-02-11 Tocagen Inc GENETERIVE VECTORS AND CYTOSINDEAMINASES
CA2782366A1 (en) * 2009-12-16 2011-07-14 Opko Curna, Llc Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
WO2013083753A2 (en) * 2011-12-07 2013-06-13 Institut Pasteur Identification of a swine parecho-like virus and applications
WO2013156989A1 (en) * 2012-04-18 2013-10-24 Ramot At Tel-Aviv University Ltd. Lipidated glycosaminoglycan particles for the delivery of nucleic acids
WO2014171526A1 (ja) * 2013-04-17 2014-10-23 国立大学法人九州大学 遺伝子改変コクサッキーウイルス
US10513711B2 (en) * 2014-08-13 2019-12-24 Dupont Us Holding, Llc Genetic targeting in non-conventional yeast using an RNA-guided endonuclease
HK1246183A1 (zh) * 2015-06-10 2018-09-07 Hookipa Biotech Gmbh Hpv疫苗
WO2017096201A1 (en) * 2015-12-02 2017-06-08 Memorial Sloan-Kettering Cancer Center Seneca valley virus (svv) cellular receptor targeted oncotherapy

Similar Documents

Publication Publication Date Title
RU2020106730A (ru) Инкапсулированные полинуклеотиды и способы их применения
JP2022516318A5 (cg-RX-API-DMAC7.html)
Amer Gene therapy for cancer: present status and future perspective
JP2020532951A5 (cg-RX-API-DMAC7.html)
JP2023078309A (ja) 腫瘍溶解性ウイルスベクター及びその使用
Antonio Chiocca Oncolytic viruses
Barth et al. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
Zhu et al. Development and application of oncolytic viruses as the nemesis of tumor cells
Campadelli‐Fiume et al. Rethinking herpes simplex virus: the way to oncolytic agents
CN113453699A (zh) 包封的rna多核苷酸及使用方法
CN113164484A (zh) 具有降低的神经毒性的hsv载体
CN113348246A (zh) 包封多核苷酸及使用方法
Parsel et al. Nucleic acid targeting: towards personalized therapy for head and neck cancer
Rayati et al. Gene therapy in glioblastoma multiforme: Can it be a role changer?
Selznick et al. Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines
Yue et al. Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives
JP7557738B2 (ja) がん治療のための腫瘍溶解性ウイルス
Mittal et al. Challenges and opportunities of gene therapy in cancer
Tahir et al. Emerging role of oncolytic viruses and stem cells in gene therapy: Should they be integrated?
Kumar et al. Gene therapy as a potential tool for treating neuroblastoma—a focused review
Choi et al. Engineered adult stem cells: a promising tool for anti-cancer therapy
JP2024512053A (ja) 転写及び翻訳の二重調節を受ける腫瘍溶解性単純ヘルペスウイルスベクター
Domingo-Musibay et al. Gene and virotherapy for hematological malignancies
Annan et al. Gene therapy in the treatment of human cancer
CN114514323A (zh) 遗传修饰的肠病毒载体